Staar Surgical Celebrates Milestone and Unveils New EVO ICL Data at ASCRS

At the ASCRS annual meeting in Boston, April 5-8, 2024, Staar Surgical will be celebrating a commercial milestone: 3 million lenses sold. Staar will be showcasing the clinical, practice and innovation advantages of the EVO ICL through a series of posters, presentations and educational programs. Staar Surgical can be found at Booth 527 and additional ASCRS event information is available at https://ascrs.org/annual-meeting.

“EVO ICL is the next logical step in refractive innovation. While adoption of any new technology takes time, EVO ICL’s adoption rate has been steadily rising since launch–achieving market leadership in key markets–and proving the viability of a global paradigm shift in refractive surgery that both expands the channel, and grows patient adoption within it,” Tom Frinzi, President and CEO of Staar Surgical, said in a company news release. “At Staar, we’re focused on raising awareness of the benefits of corneal-preserving technology, then training surgeons to be both clinically confident when they implant, and commercially confident as they integrate EVO ICL into their practices. Our ASCRS presence was designed to deliver both clinical and commercial confidence for surgeons ready to shape the future of refractive surgery.”

Data, Educational Programming and Resources Supporting Clinical Confidence

New clinical data during the scientific session continues to support EVO ICL patient advantages and provide insights to guide successful implementation in practice. On Saturday, April 6, 2024, a study showcasing “Outcomes of 229 Consecutive EVO Implantable Collamer Lenses in a US Based Single Center Study” will be presented by Taj Nasser, MD, and co-authors. This is the largest US commercial use outcomes paper to-date following FDA approval of EVO/EVO+. Also of note is a new diagnostics comparison study by J. Morgan Micheletti, MD, ABO, FACS, which demonstrates a large-scale analysis of measurement variables between eight different readily available diagnostic devices used in the evaluation of refractive surgery patients.

Staar is also supporting clinical confidence through the following educational programs and events:

• Lunch Symposium: Modernizing Refractive Surgery – Expanding Options for Myopic Patients with EVO ICL, Friday, April 5, 11:30 a.m. – 1:00 p.m. Room I53ABC
• Navigating Early Experience with EVO ICL, in-booth, Saturday, April 6, 10:00 a.m. Booth 527
• All You Wanted to Know about EVO ICL but Were Afraid to Ask, a roundtable discussion hosted at two times, Saturday, April 6, 12:00 p.m. and Sunday, April 7, 12:00 p.m. Booth 527
• Discovering EVO ICL in My Early Refractive Training, Booth 527, Saturday, April 6, 3:30 p.m.

Registration for in-booth discussions is available at: https://www.surveymonkey.com/r/STAAR-Booth
Registration for roundtable discussions is available at: https://www.surveymonkey.com/r/STAAR-table

Expanding Clinical Affairs Resources, Online and In-Booth at ASCRS

Staar is aiming to advance clinical excellence with the launch of Staar University, a new website to support clinical confidence. The website offers surgeons access to a wealth of resources, including publications, key clinical outcomes data, and more. The Staar booth will also feature a first 'Medical Affairs Information Desk,' serving as a hub for surgeons seeking medical inquiry, literature support, and specialized assistance for Investigator-Initiated Research inquiries and Independent Medical Education inquiries.

Commercial Confidence through Practice Support

Staar is leading the way in investment to grow the refractive surgery channel, and supporting surgeons who are ready to grow their business, modernize their practice and maximize their comprehensive refractive offering. Several opportunities to experience Staar's  practice advantage on display at ASCRS, include:

• Meet & Greet with Tennessee Titans Quarterback and EVO ICL advocate, Will Levis, at the STAAR Booth 527, from 11:30 a.m. – 1:00 p.m. on Saturday, April 6
• In-booth discussion on Patient-Centered Communications: Practical Strategies for Discussing EVO ICL, Saturday, April 6, 1:30 p.m. Booth 527
• In-booth discussion on Patient Acquisition: Best Practices and Behaviors, Sunday, April 7, 10:00 a.m. Booth 527

Innovation Advantage

Staar will offer an in-booth preview of Stella, Staar's latest innovation in ordering, designed to streamline and elevate the EVO ICL ordering and planning process. Appointments for Stella previews are available at https://calendly.com/staar-surgical/stella-training

For more information about EVO Implantable Collamer Lenses, visit https://evoicl.com.